16
Participants
Start Date
June 10, 2019
Primary Completion Date
July 24, 2019
Study Completion Date
July 24, 2019
MT-1186
A crossover study in which Japanese healthy subjects receive a single dose of MT-1186 under several dosing condition on Day 1, 3, 5, 7 and 24 according to their treatment sequence.
Investigational site, Tokyo
Lead Sponsor
Mitsubishi Tanabe Pharma Corporation
INDUSTRY